Back

Etiology-specific outcomes in refractory cardiogenic shock treated with Impella 2.5/CP: a 8-year real-world cohort

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Cardiogenic shock, extracorporeal membrane oxygenation, and perfusion technology Circulatory Support ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Fares Kano

University Heart Centre, Philipps University Marburg, Marburg (Germany)

5 More presentations in this session

Presentation thumbnail
Vasoplegic syndrome after cardiopulmonary bypass: prevalence, predictors, and outcomes in a Mexican cardiac surgery cohort
Doctor J. Caceres Medina (Mexico City, MX)
Abstract
Presentation thumbnail
Early left ventricular unloading with intra-aortic balloon pump versus micro-axial flow pump in cardiogenic shock supported by VA-ECMO: an international observational target trial emulation
Doctor A. Ughetto (FR)
Abstract
Presentation thumbnail
Hemoadsorption during VA-ECMO: results from the international prospective COSMOS registry
Doctor J. Kreutz (Marburg, DE)
Abstract
Presentation thumbnail
First-in-human experience with Tulyp: a novel extracorporeal perfusion system for acute limb ischemia
Mr T. Lenihan (Paris, GF)
Abstract
Presentation thumbnail
Comparative outcomes of extrathoracic, intrathoracic and facilitated transfemoral access for transcatheter aortic valve implantation: a systematic review and meta-analysis
Doctor A. Zaka (Southport, AU)
Abstract

Access the full session

Session thumbnail
Cardiogenic shock, extracorporeal membrane oxygenation, and perfusion technology

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Etiology driven mortality in cardiogenic shock
20 March 2026
thumbnail
Congress Presentation
Feasibility and safety of Impella mechanical circulatory support in different clinical scenarios: a single-centre experience
3 September 2019
thumbnail
Congress Session
Mechanical circulatory support in cardiogenic shock: risks and benefits
26 August 2023
thumbnail
Congress Presentation
Prognosis of refractory shock in de-novo versus worsening Heart Failure: Insight from the HYPO-ECMO trial.
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources